Allschwil, 4123,
Switzerland
Helvetia Biopharma Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Helvetia Biopharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 150 Helvetia Biopharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Helvetia Biopharma has purchased the following applications: Microsoft Dynamics 365 for Finance and Operations for ERP Financial in 2025, FloQast Accounting Automation Platform for Financial Consolidation and Close in 2025 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Helvetia Biopharma is running and its propensity to invest more and deepen its relationship with Microsoft , FloQast or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Helvetia Biopharma revenues, which have grown to $65.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Helvetia Biopharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Financial Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft Dynamics 365 for Finance and Operations | ERP Financial | ERP Financial Management | n/a | 2025 | 2025 |
|
EPM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| FloQast | Legacy | FloQast Accounting Automation Platform | Financial Consolidation and Close | EPM | n/a | 2025 | 2025 |
In 2025, Helvetia Biopharma implemented FloQast Accounting Automation Platform to centralize Financial Consolidation and Close capabilities and to strengthen controls ahead of its NASDAQ listing and SOX 404(b) compliance requirements. The initiative targeted the finance organization of a 150 person Swiss biopharmaceutical company, focusing on a 10 person accounting team operating across five legal entities and integrating with ERP Microsoft Dynamics 365 F&O.
The implementation configured FloQast Accounting Automation Platform to manage month end close activities, link tasks directly to control documentation, and provide governance risk and control workflows that embed control testing and evidence capture into routine close processes. Key functional capabilities implemented included close management and task orchestration, control mapping between close activities and GRC artifacts, auditor access to documentation, and structured risk assessment and control testing workflows.
Deployment architecture emphasized a cloud hosted close management layer integrated with Microsoft Dynamics 365 F&O for transactional and balance reconciliation inputs, while secure auditor access and centralized evidence storage supported audit readiness. The program was executed with technical and advisory support from FloQast and global advisory firm CFGI, completed in under two months with minimal disruption and coordinated across the companys five entities.
Governance changes shifted control ownership into the FloQast platform, replacing a spreadsheet based risk and control matrix with a fully documented control library and task linked evidence. Explicit outcomes stated by the company included elimination of manual accounting processes, improved month end visibility, enhanced controls and compliance, and more efficient audits, with FloQast becoming integral to daily accounting and statutory close workflows.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||